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Summary
Background: Pediatric cardiac catheterization is sometimes associated with serious complica-
tions. However, there are no data regarding the organization of pediatric cardiac catheterization
laboratories to minimize complications.
Objectives: The aim of this study was to determine the current organization of pediatric cardiac
catheterization laboratories with regard to patient safety in Japan.
Methods and results: We sent questionnaires to 105 institutions and obtained data from 82.
Major complications requiring surgical therapy or death occurred in 22 institutes (27%). The
incidence of major complications did not relate to the number of procedures performed. The
procedures were performed without written informed consent in 21% of all institutions. The
time to inform about the procedures was within 30min in 43 institutes (52%). A pre-procedure
meeting was held in 56 institutions (68%). The anesthetist attended the diagnostic procedures
c procedures in 53%. The drugs and deﬁbrillator for resuscitationin 23% and the therapeuti
were available in almost all institutions, but a pacemaker was not in 23 institutions (28%). The
procedures were performed under the ‘‘back-up’’ of cardiovascular surgeons in 38 institutions
(46%).
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Conclusion: There are still large numbers of institutions in Japan, which need much improvement
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Major complications occurred in 22 institutions (29%; noin the organization of pediatr
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ediatric cardiac catheterization laboratories are now
ncreasingly being used for therapeutic procedures. Also,
iagnostic catheterizations still play an important role
n hemodynamic and anatomic evaluation, especially in
omplex heart disease. Both therapeutic and diagnostic pro-
edures are associated with some risk because of their
nvasive nature [1—3]. Although a number of studies have
ddressed the complications of the invasive techniques and
easures to avoid complications, almost all of them were
elated to the techniques for the various lesions [4—8].
here has been no study that has focused on institutional
rganization for patient safety or the system of the car-
iac catheterization laboratory to minimize complications.
herefore, the present study was undertaken to review the
urrent organization of pediatric cardiac catheterization
aboratories in Japan from an aspect of patient safety in
rder to ﬁnd measures for improvement if the system has
roblems.
ethods
questionnaire was sent by mail to 105 institutions in which
embers of the Japanese Society of Pediatric Cardiology and
ardiac Surgery were employed in 2004. The following data
ere collected. Institutional background: (1) total number
f pediatric cardiac catheterizations including therapeutic
rocedures per year; (2) percentage of the therapeutic pro-
edures; (3) patients’ age: percentage of infants including
eonates and adult patients. Complications: total number
f complications occurring per year. The complications were
ivided into major and minor ones. The major complications
ncluded all events requiring surgical therapy or death. The
inor complications were deﬁned as unanticipated events
hat were resolved with medical treatment or needed the
emporal withdrawal of catheterization procedures. The
otal number of procedures and complications were asked
s a category group of number range (i.e. 0—49 procedures
er year or 50—99 procedures per year and 1—4 complica-
ions per year or 5—9 complications per year, and so on) to
acilitate a quick answer and to make analysis easy. Another
eason for this rather vague way of data collection is that
ndividual institutes or individual patients with serious com-
lications cannot be traced for the purpose of legal issues.
nstitutional system of the catheterization laboratory: (1)
nformed consent: with or without use of a written sheet
f informed consent, the time spent to inform and to obtain
onsent, and a person or persons who informed and obtained
onsent and to whom informed; (2) conference: presence
f a pre-procedure meeting in which the risk of procedures
s discussed, and the members attending the meeting; (3)
rocedures: the number of and members attending the pro-
edures; (4) equipment of the catheter laboratory focused
n patient safety; (5) presence of the cardiovascular sur-
eons’ back-up or stand-by; (6) anesthesia: a person who
r
t
5
t
grdiac catheterization laboratories as an aspect of patient safety.
ology. Published by Elsevier Ireland Ltd. All rights reserved.
erformed anesthesia; and (7) a report system for compli-
ations to the hospital or institutions.
ata analysis
ata were collected in a blinded fashion and expressed as
ean± SD, the number or percentage. The institutions were
ivided into 4 groups according to the total numbers of
rocedures performed per year: group 1: <50 procedures
er year; group 2: 50—99 procedures per year; group 3:
00—199; and group 4: >200 procedures per year. Since
he total number of procedures and complications occur-
ing per year was asked as a category group of the number
ange, the incidence of complications was estimated with
se of median number as an actual number (group 1: 25
rocedures; group 2: 75 procedures; group 3: 150 proce-
ures; group 4: 250 procedures; 1—4 complications per year:
complications; 5—9 complications per year: 7 complica-
ions; 10—19 complications per year: 15 complications; >20
omplications per year: 30 complications). When a question
ad no response, or when an answer was not clear, those
ata were excluded from analysis. Differences in incidence
mong the groups were analyzed by chi-square test. ANOVA
as used to compare variables for more than two mean val-
es. All statistical analysis was performed with Stat View
ersion 5.0 (SAS Institute, Cary, NC, USA). A p-value <0.05
as considered as statistical signiﬁcance.
esults
n total, 88 questionnaires were returned from 105 insti-
utions (response rate 84%). In 6 institutions, pediatric
atheter intervention and diagnostic catheterization were
ot performed. Thus, data from 82 institutions were used
or further analysis.
nstitutional background
here were 17 institutions in group 1, 22 in group 2, 30 in
roup 3, and 13 in group 4. The institutional background is
ummarized in Table 1. The percentage of infants was higher
n the institutions performing large numbers of cases than
n those performing relatively small numbers of cases. Also,
he percentage of therapeutic procedures was higher in the
nstitutions performing large numbers of cases than in those
erforming relatively small numbers of cases (Table 1).
omplicationsesponse from 6 institutions). They occurred in 1 institu-
ion in group 1, 7 institutions in group 2, 9 in group 3, and
in group 4. Minor complications occurred in 69 institu-
ions (84%) (8 institutions in group 1, 19 in group 2, 29 in
roup 3, 13 in group 4). The mean estimated incidence of
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Table 1 Institutional (catheterization laboratory) background.
Group 1 <50
cases/yr (n = 17)
Group 2 50—99
cases/yr (n = 22)
Group 3 100—199
cases/yr (n = 30)
Group 4 >200
case/yr (n = 13)
p-Value
Infants <0.0001
<5% 9 0 0 0
5—9% 4 2 4 1
10—19% 0 8 8 12
>20% 4 10 18 0
No response 0 2 0 0
Adults 0.24
<5% 12 14 16 7
5—9% 2 4 8 5
10—19% 1 2 5 5
>20% 2 0 1 0
No response 0 2 0 0
Therapeutic procedure <0.0001
<5% 9 5 1 0
5—9% 4 6 3 2
10—19% 3 7 5 10
>20% 1 3 21 1
No response 0 1 0 0
Table 2 Estimated incidence of complications for each group.
Group 1 (n = 17) Group 2 (n = 22) Group 3 (n = 30) Group 4 (n = 13) p-Value
Major complications 0.6 ± 2.1* 0.9 ± 1.3 0.4 ± 0.6** 0.3 ± 0.3 0.51
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AMinor complications 3.8 ± 4.1 2.6 ± 1.8
* n = 14.
** n = 27.
major and minor complications was 0.6% (n = 79) and 2.7%,
respectively. The estimated incidence of major and minor
complications for each group is shown in Table 2. It was not
different between the groups (Table 2).
Informed consent and pre-procedure meeting
Operators (pediatric cardiologists) informed and obtained
the consent in 59 (72%) institutions, operators or other
physicians (pediatric cardiologists) in 15, and other physi-
cians in 5 institutions. There were no institutions in which
co-medical staffs informed and obtained the consent. The
physicians informed both parents (mother and father) in
78 of 81 institutions (96%) and to one parent (mother or
father) in 3 institutions before the procedures. There was no
response from one institution. In the case of adult patients,
the physicians informed the patient himself or herself in
53 institutions. The data of the time spent to inform the
procedures and to obtain written informed consent are sum-
marized in Fig. 1. The time for informed consent was within
30min in 43 institutions (52%). Twenty-one percent of insti-
tutions did not use a written sheet of informed consent
(Fig. 1). There were 56 institutions (68%) in which a pre-
procedures meeting was held. In 48 institutions (59%), not
only the techniques and/or protocol of the procedure but
also the risks of procedures were discussed in the meeting.
r
n
i
t
(2.1 ± 2.4 2.0 ± 3.2 0.28
oth physicians and co-medical staff such as nurse and tech-
icians attended the meeting in only 3 institutions (5%), and
oth operators and other physicians attended it in 29 of 56
nstitutions (52%).
rocedures and equipment of cardiac laboratory
he data on the total number of attendants of procedures
ncluding operators, anesthesiologists, and technicians are
hown in Table 3. The number in attendance was more in
he therapeutic procedures than in the diagnostic ones.
urses attended the diagnostic procedures in 79 of 82 insti-
utions (96%) and the therapeutic procedures in 75 of 78
nstitutions (96%). An anesthesiologist performed the anes-
hesia for the diagnostic procedures in 10 of 82 institutions
12%) and of the therapeutic procedures in 28 of 78 insti-
utions (36%). Thus, a physician such as attending pediatric
ardiologist performed the anesthesia rather than an anes-
hesiologist in many institutions. The data on equipment in
he catheterization laboratory are summarized in Table 4.
pulse-oxymeter was available in 78 (95%). The drugs foresuscitation were available in all but a deﬁbrillator was
ot in one (1%). A temporary pacemaker was not available
n 23 institutions (28%). The procedures underwent under
he ‘‘backup’’ of cardiovascular surgeons in 38 institutions
46%).
186 Y. Mori et al.
Figure 1 Informed consent. (A) Written sheet of informed consent. (B) Time spent to inform about the procedure and to obtain
consent.
Table 3 Number of attendants in diagnostic and therapetic procedures.
Total number in attendance Number of institutions
Diagnostic procedures (n = 82) Therapeutic procedures (n = 78)
<3 4 2
4 11 4
5 23 12
6 25 24
7 11
>8 8
Table 4 Equipment and resources in the catheterization
laboratory.
Equipment/resources Number of institutions
(%) (n = 82)
Pulse-oxymeter 78 (95%)
Drugs for resuscitation 82 (100%)
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9Deﬁbrillator 81 (99%)
Temporal pacemaker 59 (72%)
Back-up of cardiovascular surgeon 38 (46%)
eport system of complications
ll complications including minor events were conveyed to
arents in 55 institutions (67%). All institutions except 4 had
report system. Of 78 institutions, the report was with use
f a written form in 76 institutions, with oral report in one,
nd no response in one.
iscussionhe role of the cardiac catheterization laboratory in pedi-
tric cardiology has evolved in the past 10—15 years.
ediatric cardiac catheterization has shifted from a diag-
ostic tool to a therapeutic one, although diagnostic
1
a
a
o
b19
17
atheterization continues to have an important role in the
valuation of patients with congenital heart disease. Several
tudies have demonstrated that the rate of complications
s higher in therapeutic procedures than that in diagnos-
ic procedures [2,9,10]. As the numbers of the therapeutic
rocedures are increasing, the institutional system or the
ystem for the cardiac catheterization laboratory minimiz-
ng complications is becoming increasingly important in
ddition to the technical methods of avoiding complica-
ions. In our study, we clariﬁed the current organization of
he pediatric cardiac catheterization laboratory for patient
afety in Japan.
ncidence of complications
n the past 10—15 years, few reports have addressed the
omplications related to pediatric cardiac catheterization
1,2]. A review between 1986 and 1988 from University of
alifornia, San Francisco [1] reported that major complica-
ions including death occurred in 1.5% and minor in 6.8% or
.6% if all adverse events were included. Between 1987 and
993, the study from Toronto [2] found 102 major (2.1%)
nd 458 minor complications (9.2%) from 4952 procedures
nd that death occurred in 0.14% of procedures. The review
f Japanese Pediatric Interventional Cardiology conducted
etween 2004 and 2008 [11] reported that deaths occurred
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TSystem of pediatric catheterization laboratory
in 0.13% and major complications in 3.7% of 8446 therapeu-
tic procedures, although the complications of the diagnostic
procedures were not included. Since the methods of estima-
tion for the incidence and deﬁnition of complications were
different from those in our study, we could not compare
the incidence itself reported previously. In addition, we did
not address the accurate incidence of pediatric catheteri-
zation because of the methological limitation of estimating
incidence. The importance was that the major complica-
tions such as death were not yet eliminated completely,
even though techniques or devices for pediatric catheteri-
zation have dramatically improved over the past decades. In
general, the incidence of complications may partly depend
on the operator’s experience or skill that was considered to
relate to the numbers of cases of catheterization performed.
However, the number of cases performed at an institutional
level did not relate to the incidence of complications in
our study. This may be related to the facts that procedures
were performed in high-risk patients including newborns or
infants in institutions performing a large number of cases,
and that therapeutic procedures were performedmore often
than in the institutions with less volume of patients. Another
possibility may be that multiple operators performed the
procedures, thus an operator did not accumulate his/her
skill in the institutions performing large numbers of cases.
Informed consent and pre-procedure meeting
As patients become more educated and have a growing
desire to know about the procedures in detail, informed
consent has become an important part of medical prac-
tice. Medical staffs are now required to attempt to explain
procedures and their beneﬁts, to offer other diagnostic
or therapeutic options, and to convey possible risks and
complications before performing cardiac catheterization.
Our study demonstrated that the time spent for informed
consent was within 30min in 50% and a written sheet of
informed consent was not used in about 20% of cardiac
catheterization laboratories. The adequate time required
for informing patients or their parents and obtaining consent
is not clear. However, parents and/or patients do not have
medical knowledge in general. Therefore we believe that
it takes more than 30min to detail the contents described
above (i.e. explanation of procedures, their beneﬁts and
risks, and other options) and to answer the questions that
the parents and/or a patient have. In addition, the chance of
informing about the procedure is usually once for each pro-
cedure in many Japanese institutions. Thus, 30min or less
seems to be too short to fully inform about cardiac catheter-
ization and to obtain a fully understood informed consent.
The best way to meet the above requirements could be to
provide a detailed written information sheet that outlines
a procedure and all possible complications. The use of a
detailed written information sheet is much help for patients
or patients’ parents to understand the procedures. Regard-
ing pre-procedure meetings, Bridges et al. reported that it
was extremely useful to discuss the catheterization plan and
anticipated complications prior to each procedure among
the physicians, nurses, and technicians involved [12]. It is
very important that all attendants of cardiac catheterization
have knowledge of the patient’s data and catheterization
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lan. This may be crucial for prevention or management
f unanticipated adverse events during cardiac catheter-
zation, resulting in minimizing complications. Thus, the
re-procedure meeting where all attendants discuss the risk
f the procedure should be held prior to each procedure.
rocedures, facility and equipments of
atheterization laboratory
here are no data regarding the adequate number of atten-
ants in the catheterization laboratory. However, at least 4
r 5 attendants excluding the radiologist seem to be neces-
ary for performing catheterization (one or two operators,
n anesthetist, one nurse, one technician). If the number
f attendants is less than 4 or 5, an operator would not be
ble to concentrate on the procedure. This may lead to mis-
akes resulting in serious complications. Furthermore, it is
esirable that anesthesiologists should perform the anes-
hesia. However, a physician who did not have a license
f anesthesiologist played a role as the anesthesiologist in
any institutions. This may be due to the lack of enough
nesthesiologists in each institution.
All equipment shown in Table 4 is mandatory for patient
afety in the catheterization laboratory. About 30% of lab-
ratories did not have the temporal pacemaker, although
his should be equipped in all laboratories for the emer-
ency treatment of arrhythmia. Also, it is problematic that
ver half of Japanese pediatric catheterization laborato-
ies were without surgical back-up. The American College
f Cardiology/American Heart Association task force on
ardiac catheterization states that the procedures in pedi-
tric patients should be performed with immediate access
o pediatric cardiovascular surgeon and operating facilities
13]. The British Pediatric Cardiac Association also recom-
ends the procedures under the support of a surgical system
14]. Thus, it is clear that all procedures should be per-
ormed under the cardiovascular surgeon’s support or back
p.
eport system of complications
ll complications including minor events should be conveyed
o parents or patients, although over 30% of institutions
ere not doing so. The Japanese government recommends
hat all adverse events related to medical care should be
eported to institutions. Almost all institutions reported hav-
ng a report system for complications, although we could not
larify whether all complications were reported using this
ystem. In addition, the use of a written sheet is considered
o be more preferable than oral report for later data analysis
f the institutions.
onclusions
he organization of catheterization laboratories to minimize
omplications is not sufﬁcient in many Japanese institu-
ions. All pediatric catheterization laboratories have to
e-organize and improve the patient safety system, because
he number of cases performed did not relate to the inci-
ence of complications.
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